Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Therapeutic angiogenesis: theoretic problems using vascular endothelial growth factor.

I Baumgartner¹

¹University Hospital, Swiss Cardiovascular Center, Division of Angiology, Freiburgstrasse, 3010 Bern, Switzerland.

Current Cardiology Reports

|September 12, 2000

Summary

Therapeutic angiogenesis using vascular endothelial growth factor (VEGF) gene transfer shows promise for ischemic vascular disease. However, potential risks like tumor angiogenesis warrant careful consideration for safe clinical application.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Adherence to Statin Therapy Drives Survival of Patients with Symptomatic Peripheral Artery Disease.

European cardiology·2020

Same author

Ultrasound-assisted versus conventional catheter-directed thrombolysis for acute iliofemoral deep vein thrombosis: 1-year follow-up data of a randomized-controlled trial.

Journal of thrombosis and haemostasis : JTH·2017

Same author

Hemodynamic Characterization of Peripheral Arterio-venous Malformations.

Annals of biomedical engineering·2017

Same author

ISVI-IUA consensus document diagnostic guidelines of vascular anomalies: vascular malformations and hemangiomas.

International angiology : a journal of the International Union of Angiology·2014

Same author

Guideline. Diagnosis and treatment of venous malformations. consensus document of the international union of phlebology (iup): updated-2013.

International angiology : a journal of the International Union of Angiology·2014

Same author

Diagnosis and Treatment of Venous Malformations. Consensus Document of the International Union of Phlebology (IUP): updated 2013.

International angiology : a journal of the International Union of Angiology·2014

Area of Science:

Biotechnology
Vascular Biology
Gene Therapy

Background:

Ischemic vascular disease presents a significant therapeutic challenge.
Angiogenic growth factors, particularly vascular endothelial growth factor (VEGF), are being explored for therapeutic angiogenesis.
Intramuscular gene transfer of VEGF has demonstrated potential in treating chronic critical limb ischemia.

Purpose of the Study:

To explore the theoretical challenges and potential risks associated with using naked plasmid DNA encoding VEGF for therapeutic angiogenesis.
To discuss the dual nature of angiogenesis, highlighting both its benefits and detrimental consequences in non-target tissues.
To address the ongoing controversy regarding the mechanisms behind the clinical benefits of growth factors in gene therapy.

Main Methods:

Related Experiment Videos

Review of existing experimental and clinical data on VEGF gene transfer.
Theoretical analysis of the risks and benefits of therapeutic angiogenesis.
Discussion of the challenges in utilizing naked plasmid DNA for gene transfer.

Main Results:

Short-term increases in circulating VEGF are considered safe based on current data.
The potential for tumor or plaque angiogenesis remains a theoretical concern.
The precise mechanisms of clinical benefits from growth factor gene therapy are still debated.

Conclusions:

While VEGF gene therapy holds promise for ischemic vascular disease, careful consideration of potential risks is essential.
Further research is needed to fully understand and mitigate the risks associated with therapeutic angiogenesis.
The use of naked plasmid DNA for VEGF delivery requires further investigation into its safety and efficacy profile.